The overall objective of this call order is to support the planning, implementation, and reporting of one mixed-methods evaluation study examining the implementation, outcomes, and potential…

Ended Awarded Last action

Contract number
75F40123F19006
Awardee
Awarding agency
Obligated
$965,878

Award facts

Contract value 100% obligated
$965,878.00 Current and potential, with all options
Completion date 100% complete
Current and potential, with all options
Contracting staff
Set-aside
No set-aside
Competition
Full and Open Competition Multiple Award, Fair Opportunity
Pricing
Labor Hours
Place of performance
Durham, NC 27709, USA
Legislative mandates

Award details come from SAM.gov/FPDS.

Transactions

Action Obligated Date
Supplemental Agreement for work within scope P00002 · EOI::ending radical and wasteful government DEI programs and preferencing (january 20, 2025)::EOI bilateral modification to descope diversity, equity, and… $0
Supplemental Agreement for work within scope P00001 · This bilateral modification is being issued to change the contract type of the order from a firm fixed price to a time and material call order $0
Original award $965,878

About this award

This is a federal contract award from the Food and Drug Administration (FDA) to Research Triangle Institute (RTI International), a non-profit research organization. The overall objective of this call order is to support the planning, implementation, and reporting of one mixed-methods evaluation study examining the implementation, outcomes, and potential unintended consequences associated with sales restrictions. The contract is a BPA Call under the Multiple Award Schedule (MAS) program, with a ceiling value of $965,878.00 and a period of performance through September 25, 2025. The award does not have a set-aside designation. RTI International has a history of securing prime contract and grant awards from numerous federal agencies, including the FDA, to provide research, technical assistance, and program evaluation services across public health, environmental, and social policy domains.

Description

The overall objective of this call order is to support the planning, implementation, and reporting of one mixed-methods evaluation study examining the implementation, outcomes, and potential unintended consequences associated with sales restrictions

Quick answers

Who was awarded contract 75F40123F19006?

75F40123F19006 was awarded to Research Triangle Institute by Food and Drug Administration (Department of Health and Human Services) on September 26, 2023.

How much is contract 75F40123F19006 worth?

The government has obligated $965,878 on 75F40123F19006.

Is contract 75F40123F19006 an order under another contract?

Yes. 75F40123F19006 is a BPA call under GS00F354CA-75F40118A10042, a blanket purchase agreement, on Multiple Award Schedule (MAS).

Was contract 75F40123F19006 competed?

The extent of competition for 75F40123F19006 was full and open competition.

On GovTribe

See this award's full record

  • Every transaction and funding action
  • The awardee's other awards and teaming partners
  • Similar awards and recompete opportunities
  • Ask GovTribe AI about this award